Skip to main content

Advertisement

Tumor immune microenvironment and immunotherapy

Read new articles in our current special issue, including the guest editors' editorial and longitudinal monitoring of the neoantigen landscape in colorectal cancer. 

Deadline extended: Translating the microbiome

Submit to our special issue, guest edited by Ramnik Xavier. We aim to capture insights into all aspects of the human microbiome in health and disease.

Novel method for epilepsy phenotypes

Fereydoun Hormozdiari and colleagues present MAGI-S, a method to differentiate epilepsy phenotypes from other neurodevelopmental disorders. 

Gut microbiome in melanoma

Jiyoung Ahn and colleagues describe gut microbiome effects on immunotherapy responses in melanoma patients. 

A Decade of Genome Medicine

2019 is the 10th anniversary of Genome Medicine! This collection revisits some of our favorite articles. 

Reviews, Research Highlights and Commentaries

Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:

Reviews

Research Highlights

Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)

Articles

Focus: Breast Cancer

Read the latest papers on Breast Cancer across BMC flagship journals.

Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial
Joaquin Gavila et al.

Published in BMC Medicine 09 January 2019

VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX
Florian Bonin et al.

Published in BMC Biology 02 October 2018

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Elen Kristine Hoglander et al.

Published in Genome Medicine 29 November 2018

VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer​​​​​​​
Andrew N. Holding et al.

Published in Genome Biology 13 May 2019

Aims and scope

Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries. 

Article collections

Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda

Special issue
From genome integrity to cancer
Guest editor: Serena Nik-Zainal

Special issue
Genomics of infection and immunity
Guest editors: Bali Pulendran and Mark Davis

Special issue
Disease Neurogenomics
Guest editors: Joseph Buxbaum and Catalina Betancur

See all article collections

Reviews, Research Highlights and Commentaries

Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:

Reviews

Research Highlights

Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)

Latest Tweets

Advertisement

2018 Journal Metrics

Advertisement